This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1ayp

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1ayp" size="450" color="white" frame="true" align="right" spinBox="true" caption="1ayp, resolution 2.57&Aring;" /> '''A PROBE MOLECULE CO...)
Line 1: Line 1:
-
[[Image:1ayp.gif|left|200px]]<br />
+
[[Image:1ayp.gif|left|200px]]<br /><applet load="1ayp" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1ayp" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1ayp, resolution 2.57&Aring;" />
caption="1ayp, resolution 2.57&Aring;" />
'''A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT'''<br />
'''A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT'''<br />
==Overview==
==Overview==
-
It is often found in the crystallization of enzyme-inhibitor complexes, that an inhibitor causes crystal packing which is different to that of, native protein. This is the case for crystals of human non-pancreatic, secreted phospholipase A(2) (124 residues) containing six molecules in the, asymmetric unit when the protein is complexed with a potential acylamino, analogue of a phospholid. The hexameric structure was determined by, molecular replacement using the structure of monomeric native protein as a, probe. As an extension to the experiment, it was tested whether a backbone, polypeptide composed of 17% of a known monomeric structure could find its, correct position on a target molecule in molecular replacement. A probe, model composed of the backbone atoms of the N-terminal 77 residues of, lysine-, arginine-, ornithine-binding protein (LAO, a total of 238, residues) liganded with lysine correctly finds its position on LAO, liganded with histidine which crystallizes as a monomer in the asymmetric, unit. The results indicate that as little as 17% of total diffracting, matter can be used in molecular replacement to solve crystal structures or, to obtain phase information which can be combined with phases obtained by, the isomorphous-replacement method.
+
It is often found in the crystallization of enzyme-inhibitor complexes that an inhibitor causes crystal packing which is different to that of native protein. This is the case for crystals of human non-pancreatic secreted phospholipase A(2) (124 residues) containing six molecules in the asymmetric unit when the protein is complexed with a potential acylamino analogue of a phospholid. The hexameric structure was determined by molecular replacement using the structure of monomeric native protein as a probe. As an extension to the experiment, it was tested whether a backbone polypeptide composed of 17% of a known monomeric structure could find its correct position on a target molecule in molecular replacement. A probe model composed of the backbone atoms of the N-terminal 77 residues of lysine-, arginine-, ornithine-binding protein (LAO, a total of 238 residues) liganded with lysine correctly finds its position on LAO liganded with histidine which crystallizes as a monomer in the asymmetric unit. The results indicate that as little as 17% of total diffracting matter can be used in molecular replacement to solve crystal structures or to obtain phase information which can be combined with phases obtained by the isomorphous-replacement method.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1AYP is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with CA and INB as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Phospholipase_A(2) Phospholipase A(2)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.1.4 3.1.1.4] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1AYP OCA].
+
1AYP is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=CA:'>CA</scene> and <scene name='pdbligand=INB:'>INB</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Phospholipase_A(2) Phospholipase A(2)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.1.4 3.1.1.4] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AYP OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Phospholipase A(2)]]
[[Category: Phospholipase A(2)]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Oh, B.H.]]
+
[[Category: Oh, B H.]]
[[Category: CA]]
[[Category: CA]]
[[Category: INB]]
[[Category: INB]]
[[Category: hydrolase]]
[[Category: hydrolase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:03:51 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:49:43 2008''

Revision as of 09:49, 21 February 2008


1ayp, resolution 2.57Å

Drag the structure with the mouse to rotate

A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT

Contents

Overview

It is often found in the crystallization of enzyme-inhibitor complexes that an inhibitor causes crystal packing which is different to that of native protein. This is the case for crystals of human non-pancreatic secreted phospholipase A(2) (124 residues) containing six molecules in the asymmetric unit when the protein is complexed with a potential acylamino analogue of a phospholid. The hexameric structure was determined by molecular replacement using the structure of monomeric native protein as a probe. As an extension to the experiment, it was tested whether a backbone polypeptide composed of 17% of a known monomeric structure could find its correct position on a target molecule in molecular replacement. A probe model composed of the backbone atoms of the N-terminal 77 residues of lysine-, arginine-, ornithine-binding protein (LAO, a total of 238 residues) liganded with lysine correctly finds its position on LAO liganded with histidine which crystallizes as a monomer in the asymmetric unit. The results indicate that as little as 17% of total diffracting matter can be used in molecular replacement to solve crystal structures or to obtain phase information which can be combined with phases obtained by the isomorphous-replacement method.

Disease

Known diseases associated with this structure: Colorectal cancer, sporadic OMIM:[172411]

About this Structure

1AYP is a Single protein structure of sequence from Homo sapiens with and as ligands. Active as Phospholipase A(2), with EC number 3.1.1.4 Full crystallographic information is available from OCA.

Reference

A probe molecule composed of seventeen percent of total diffracting matter gives correct solutions in molecular replacement., Oh BH, Acta Crystallogr D Biol Crystallogr. 1995 Mar 1;51(Pt 2):140-4. PMID:15299314

Page seeded by OCA on Thu Feb 21 11:49:43 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools